Moderna (MRNA) Other Operating Expenses (2017 - 2026)
Moderna (MRNA) posted quarterly Other Operating Expenses of $93.0 million for Q2 2026, down 21.85% year-over-year from $119.0 million in Q2 2025, and down 90.26% on a QoQ basis from $955.0 million in Q1 2026.
Moderna (MRNA) Other Operating Expenses (2017 - 2026) Analysis & Trends
Moderna has reported Other Operating Expenses for 9 years, with the latest figure at $93.0 million in Q2 2026.
- Other Operating Expenses for Q2 2026 came in at $93.0 million, down 21.85% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.7 billion (up 16.76% YoY), and the FY2025 annual result was $868.0 million, down 40.71% from the prior year.
- Other Operating Expenses retreated to $93.0 million in Q2 2026, from $955.0 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $2.2 billion in Q3 2023 and troughed at $90.0 million in Q1 2025.
- A 5-year average of $749.4 million and a median of $735.0 million in 2023 frame the typical range for Other Operating Expenses.
- The widest annual swing landed in 2024, when Other Operating Expenses tumbled 87.88%; it then jumped 961.11% in 2026.
- A 5-year view of Other Operating Expenses shows it stood at $1.9 billion in 2022, then tumbled by 51.56% to $929.0 million in 2023, then dropped by 20.45% to $739.0 million in 2024, then plunged by 38.84% to $452.0 million in 2025, then sank by 79.42% to $93.0 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $93.0 million in Q2 2026, $955.0 million in Q1 2026, and $452.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.00 Mn |
| Mar 31, 2026 | 955.00 Mn |
| Dec 31, 2025 | 452.00 Mn |
| Sep 30, 2025 | 207.00 Mn |
| Jun 30, 2025 | 119.00 Mn |
| Mar 31, 2025 | 90.00 Mn |
| Dec 31, 2024 | 739.00 Mn |
| Sep 30, 2024 | 514.00 Mn |
| Jun 30, 2024 | 115.00 Mn |
| Mar 31, 2024 | 96.00 Mn |
| Dec 31, 2023 | 929.00 Mn |
| Sep 30, 2023 | 2.24 Bn |
| Jun 30, 2023 | 731.00 Mn |
| Mar 31, 2023 | 792.00 Mn |
| Dec 31, 2022 | 1.92 Bn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.38 Bn |
| Mar 31, 2022 | 1.02 Bn |
| Dec 31, 2021 | 952.00 Mn |
| Sep 30, 2021 | 722.00 Mn |